| Ipsen Pharma Schweiz GmbH - Relfydess 150 units/ 1,5 ml, Injektionslösung | | 69620 | | 01 | | Relfydess 150 units/ 1,5 ml | | Injektionslösung | | M03AX01 | | Botulismustoxin | | 10.03.2025 | | |
| | Composition | | toxinum botulinicum A (stirpis I01) 150 U., dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, kalii chloridum, natrii chloridum, polysorbatum 80, tryptophanum, aqua ad iniectabile q.s. ad solutionem pro 1.5 ml corresp. natrium 5.4 mg et kalium 0.18 mg. | | Packungsbestandteile | | Solution injectable | | | | | | Principe actif | Concentr. |
|---|
| Toxinum Botulinicum a (Stirpis I01) | 150U. / 1.5ml |
| | | | Agents auxilliaires |
|---|
| Disodium Phosphate Dihydrate | | Potassium Chlorure | | Sodium Chlorure | | Sodium Dihydrogenophosphate Dihydrate | | Polysorbatum 80 | | Tryptophan |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | | | | A | | Non | | 002 | 10 | | | A | | Non |
|
|
